Cargando…

Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

Detalles Bibliográficos
Autores principales: Uemura, Hiroji, Koroki, Yosuke, Iwaki, Yuki, Imanaka, Keiichiro, Kambara, Takeshi, Lopez-Gitlitz, Angela, Smith, Andressa, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583189/
https://www.ncbi.nlm.nih.gov/pubmed/33092574
http://dx.doi.org/10.1186/s12894-020-00739-7
_version_ 1783599350870441984
author Uemura, Hiroji
Koroki, Yosuke
Iwaki, Yuki
Imanaka, Keiichiro
Kambara, Takeshi
Lopez-Gitlitz, Angela
Smith, Andressa
Uemura, Hirotsugu
author_facet Uemura, Hiroji
Koroki, Yosuke
Iwaki, Yuki
Imanaka, Keiichiro
Kambara, Takeshi
Lopez-Gitlitz, Angela
Smith, Andressa
Uemura, Hirotsugu
author_sort Uemura, Hiroji
collection PubMed
description
format Online
Article
Text
id pubmed-7583189
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75831892020-10-26 Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study Uemura, Hiroji Koroki, Yosuke Iwaki, Yuki Imanaka, Keiichiro Kambara, Takeshi Lopez-Gitlitz, Angela Smith, Andressa Uemura, Hirotsugu BMC Urol Correction BioMed Central 2020-10-22 /pmc/articles/PMC7583189/ /pubmed/33092574 http://dx.doi.org/10.1186/s12894-020-00739-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Uemura, Hiroji
Koroki, Yosuke
Iwaki, Yuki
Imanaka, Keiichiro
Kambara, Takeshi
Lopez-Gitlitz, Angela
Smith, Andressa
Uemura, Hirotsugu
Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title_full Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title_fullStr Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title_full_unstemmed Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title_short Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study
title_sort correction to: skin rash following administration of apalutamide in japanese patients with advanced prostate cancer: an integrated analysis of the phase 3 spartan and titan studies and a phase 1 open-label study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583189/
https://www.ncbi.nlm.nih.gov/pubmed/33092574
http://dx.doi.org/10.1186/s12894-020-00739-7
work_keys_str_mv AT uemurahiroji correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT korokiyosuke correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT iwakiyuki correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT imanakakeiichiro correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT kambaratakeshi correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT lopezgitlitzangela correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT smithandressa correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy
AT uemurahirotsugu correctiontoskinrashfollowingadministrationofapalutamideinjapanesepatientswithadvancedprostatecanceranintegratedanalysisofthephase3spartanandtitanstudiesandaphase1openlabelstudy